Cargando…
Mitochondria and Cancer Recurrence after Liver Transplantation—What Is the Benefit of Machine Perfusion?
Tumor recurrence after liver transplantation has been linked to multiple factors, including the recipient’s tumor burden, donor factors, and ischemia-reperfusion injury (IRI). The increasing number of livers accepted from extended criteria donors has forced the transplant community to push the devel...
Autores principales: | Parente, Alessandro, Flores Carvalho, Mauricio, Eden, Janina, Dutkowski, Philipp, Schlegel, Andrea |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9456431/ https://www.ncbi.nlm.nih.gov/pubmed/36077144 http://dx.doi.org/10.3390/ijms23179747 |
Ejemplares similares
-
Machine Perfusion for Extended Criteria Donor Livers: What Challenges Remain?
por: Widmer, Jeannette, et al.
Publicado: (2022) -
Impact of Machine Perfusion on Biliary Complications after Liver Transplantation
por: Schlegel, Andrea, et al.
Publicado: (2018) -
Impact of Machine Perfusion on the Immune Response After Liver Transplantation – A Primary Treatment or Just a Delivery Tool
por: Panconesi, Rebecca, et al.
Publicado: (2022) -
Endothelial Cells and Mitochondria: Two Key Players in Liver Transplantation
por: Parente, Alessandro, et al.
Publicado: (2023) -
Preventing Tumour Recurrence after Liver Transplantation: The Role of Machine Perfusion
por: Boteon, Yuri, et al.
Publicado: (2020)